Experienced in Judge Misch Wright Syndrome

Dr. Joyce Teng

Pediatrics
Lucille Packard Children's Hospital 030962
770 Welch Rd, 
Palo Alto, CA 
Experienced in Judge Misch Wright Syndrome
Lucille Packard Children's Hospital 030962
770 Welch Rd, 
Palo Alto, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joyce Teng is a Pediatrics provider in Palo Alto, California. Dr. Teng is rated as an Experienced provider by MediFind in the treatment of Judge Misch Wright Syndrome. Her top areas of expertise are Lamellar Ichthyosis, Nonbullous Congenital Ichthyosiform Erythroderma, Nevoid Basal Cell Carcinoma Syndrome, Aplasia Cutis Congenita, and Liver Embolization.

Her clinical research consists of co-authoring 114 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatrics
Licenses
Dermatology in CA
Hospital Affiliations
Lucile Salter Packard Children's Hsp At Stanford
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Contra Costa Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Health Plan of San Mateo
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Highmark
  • EPO
  • HMO
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Valley Health
  • HMO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Health Advantage
  • HMO
  • INSURANCE PLAN
  • MEDICARE DISCOUNT CARD
  • MEDICARE MAPD
View 17 Less Insurance Carriers -

Locations

Lucille Packard Children's Hospital 030962
770 Welch Rd, Palo Alto, CA 94304
Call: 650-721-1227
Other Locations
Lucile Packard Children's Hospital Stanford
725 Welch Rd, Palo Alto, CA 94304
Call: 650-497-8000

Additional Areas of Focus

Dr. Teng has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Managed Access Program (MAP) Cohort Treatment Plan CBYL719F12001M to Provide Access to Alpelisib (BYL719) for Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Managed Access Program (MAP) Cohort Treatment Plan CBYL719F12001M to Provide Access to Alpelisib (BYL719) for Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Enrollment Status: Available
Publish Date: December 02, 2025
Intervention Type: Drug
Safety and Effect of LEO 90100 Aerosol Foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) With Plaque Psoriasis
Safety and Effect of LEO 90100 Aerosol Foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) With Plaque Psoriasis
Enrollment Status: Completed
Publish Date: March 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
Enrollment Status: Completed
Publish Date: August 29, 2024
Intervention Type: Drug
Study Drug: QTORIN rapamycin anhydrous gel
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase I/II, Closed Label, Randomized, Pilot Study for the Safety and Efficacy of TolaSure Gel, 5% w/w Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex (TAMES)
A Phase I/II, Closed Label, Randomized, Pilot Study for the Safety and Efficacy of TolaSure Gel, 5% w/w Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex (TAMES)
Enrollment Status: Completed
Publish Date: September 11, 2023
Intervention Type: Drug
Study Drug: TolaSure
Study Phase: Phase 1
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations
Enrollment Status: Completed
Publish Date: November 17, 2022
Intervention Type: Drug, Other
Study Drug: Sildenafil
Study Phase: Phase 2
Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations
Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations
Enrollment Status: Terminated
Publish Date: August 04, 2022
Intervention Type: Drug
Study Drug: VT30
Study Phase: Phase 1/Phase 2
A Prospective, Double-Blind, Cross-Over, Pilot Study to Assess Safety and Efficacy of Topical Sirolimus 2% in the Treatment of Plantar Blistering in Patients With Epidermolysis Bullous Simplex (EBS)
A Prospective, Double-Blind, Cross-Over, Pilot Study to Assess Safety and Efficacy of Topical Sirolimus 2% in the Treatment of Plantar Blistering in Patients With Epidermolysis Bullous Simplex (EBS)
Enrollment Status: Completed
Publish Date: March 09, 2022
Intervention Type: Drug
Study Drugs: Sirolimus, Vehicle
Study Phase: Phase 2
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: September 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Enrollment Status: Terminated
Publish Date: November 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

114 Total Publications

Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex Severity.
Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex Severity.
Journal: JAMA dermatology
Published: October 15, 2025
View All 114 Publications
Similar Doctors
Distinguished in Judge Misch Wright Syndrome
Dr. Dawn Siegel
Pediatrics
Distinguished in Judge Misch Wright Syndrome
Dr. Dawn Siegel
Pediatrics

Child And Adolescent Mental Health-Stanford Children's Health Specialty Services-Sunnyvale

1195 W Fremont Ave, 
Sunnyvale, CA 
 (8.5 miles away)
650-721-1227
Languages Spoken:
English
See accepted insurances

Dawn Siegel is a Pediatrics provider in Sunnyvale, California. Dr. Siegel is rated as an Elite provider by MediFind in the treatment of Judge Misch Wright Syndrome. Her top areas of expertise are PHACE Syndrome, Hemangioma, Aplasia Cutis Congenita, and Vascular Birthmark.

Advanced in Judge Misch Wright Syndrome
Dr. Derek Chu
Pediatrics
Advanced in Judge Misch Wright Syndrome
Dr. Derek Chu
Pediatrics

Child And Adolescent Mental Health-Stanford Children's Health Specialty Services-Sunnyvale

1195 W Fremont Ave, 
Sunnyvale, CA 
 (8.5 miles away)
650-721-1227
Languages Spoken:
English
See accepted insurances

Derek Chu is a Pediatrics provider in Sunnyvale, California. Dr. Chu is rated as an Advanced provider by MediFind in the treatment of Judge Misch Wright Syndrome. His top areas of expertise are Linear Hamartoma Syndrome, Vascular Birthmark, Familial Multiple Nevi Flammei, and Stork Bite.

Experienced in Judge Misch Wright Syndrome
Dr. Ann Marqueling
Pediatrics
Experienced in Judge Misch Wright Syndrome
Dr. Ann Marqueling
Pediatrics

Office

770 Welch Rd Ste 300, 
Palo Alto, CA 
 (4.3 miles away)
650-721-1227
Languages Spoken:
English
See accepted insurances

Ann Marqueling is a Pediatrics provider in Palo Alto, California. Dr. Marqueling is rated as an Advanced provider by MediFind in the treatment of Judge Misch Wright Syndrome. Her top areas of expertise are Linear Hamartoma Syndrome, Stork Bite, Vascular Birthmark, and Familial Multiple Nevi Flammei.

VIEW MORE JUDGE MISCH WRIGHT SYNDROME DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Teng's expertise for a condition
ConditionClose
  • Elite
  • Aplasia Cutis Congenita
    Dr. Teng is
    Elite
    . Learn about Aplasia Cutis Congenita.
    See more Aplasia Cutis Congenita experts
  • Dominant Dystrophic Epidermolysis Bullosa
    Dr. Teng is
    Elite
    . Learn about Dominant Dystrophic Epidermolysis Bullosa.
    See more Dominant Dystrophic Epidermolysis Bullosa experts
  • Dowling-Meara Epidermolysis Bullosa Simplex
    Dr. Teng is
    Elite
    . Learn about Dowling-Meara Epidermolysis Bullosa Simplex.
    See more Dowling-Meara Epidermolysis Bullosa Simplex experts
  • Lamellar Ichthyosis
    Dr. Teng is
    Elite
    . Learn about Lamellar Ichthyosis.
    See more Lamellar Ichthyosis experts
  • Nevoid Basal Cell Carcinoma Syndrome
    Dr. Teng is
    Elite
    . Learn about Nevoid Basal Cell Carcinoma Syndrome.
    See more Nevoid Basal Cell Carcinoma Syndrome experts
  • Nonbullous Congenital Ichthyosiform Erythroderma
    Dr. Teng is
    Elite
    . Learn about Nonbullous Congenital Ichthyosiform Erythroderma.
    See more Nonbullous Congenital Ichthyosiform Erythroderma experts
  • Distinguished
  • Arteriovenous Malformation
    Dr. Teng is
    Distinguished
    . Learn about Arteriovenous Malformation.
    See more Arteriovenous Malformation experts
  • Clouston Syndrome
    Dr. Teng is
    Distinguished
    . Learn about Clouston Syndrome.
    See more Clouston Syndrome experts
  • Ectodermal Dysplasias
    Dr. Teng is
    Distinguished
    . Learn about Ectodermal Dysplasias.
    See more Ectodermal Dysplasias experts
  • Epidermal Nevus
    Dr. Teng is
    Distinguished
    . Learn about Epidermal Nevus.
    See more Epidermal Nevus experts
  • Epidermolysis Bullosa
    Dr. Teng is
    Distinguished
    . Learn about Epidermolysis Bullosa.
    See more Epidermolysis Bullosa experts
  • Familial Multiple Nevi Flammei
    Dr. Teng is
    Distinguished
    . Learn about Familial Multiple Nevi Flammei.
    See more Familial Multiple Nevi Flammei experts
View All 11 Distinguished Conditions
  • Advanced
  • 2q37 Deletion Syndrome
    Dr. Teng is
    Advanced
    . Learn about 2q37 Deletion Syndrome.
    See more 2q37 Deletion Syndrome experts
  • Aase Syndrome
    Dr. Teng is
    Advanced
    . Learn about Aase Syndrome.
    See more Aase Syndrome experts
  • Abdominal Cystic Lymphangioma
    Dr. Teng is
    Advanced
    . Learn about Abdominal Cystic Lymphangioma.
    See more Abdominal Cystic Lymphangioma experts
  • Abruzzo-Erickson Syndrome
    Dr. Teng is
    Advanced
    . Learn about Abruzzo-Erickson Syndrome.
    See more Abruzzo-Erickson Syndrome experts
  • Acrodermatitis Enteropathica
    Dr. Teng is
    Advanced
    . Learn about Acrodermatitis Enteropathica.
    See more Acrodermatitis Enteropathica experts
  • Acrokeratoelastoidosis of Costa
    Dr. Teng is
    Advanced
    . Learn about Acrokeratoelastoidosis of Costa.
    See more Acrokeratoelastoidosis of Costa experts
View All 119 Advanced Conditions
  • Experienced
  • Acanthosis Nigricans
    Dr. Teng is
    Experienced
    . Learn about Acanthosis Nigricans.
    See more Acanthosis Nigricans experts
  • Acne
    Dr. Teng is
    Experienced
    . Learn about Acne.
    See more Acne experts
  • Acrogeria, Gottron Type
    Dr. Teng is
    Experienced
    . Learn about Acrogeria, Gottron Type.
    See more Acrogeria, Gottron Type experts
  • Actinic Keratosis
    Dr. Teng is
    Experienced
    . Learn about Actinic Keratosis.
    See more Actinic Keratosis experts
  • AEC Syndrome
    Dr. Teng is
    Experienced
    . Learn about AEC Syndrome.
    See more AEC Syndrome experts
  • Alopecia Totalis
    Dr. Teng is
    Experienced
    . Learn about Alopecia Totalis.
    See more Alopecia Totalis experts
View All 134 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.